While scientists have known for more than two decades that all cells use a strategy called RNA interference to regulate gene ...

In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small interfering RNA therapy with an immunomodulator led to substantial declines in blood ...

While scientists have known for over two decades that all cells use a strategy called RNA interference to regulate gene ...

WEST LAFAYETTE, Ind. — Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to grow and spread, a substantial advantage over even ...

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...

This deal strengthens GSK’s focus on addressing the complications of obesity, while restocking the company’s pipeline amid key patent expiries.

Small interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases. However, siRNA drugs have challenges because siRNAs often silence ...

Under the terms of the agreement, GSK will obtain exclusive worldwide rights to develop, manufacture, and commercialize two of Frontier Biotech's Small Interfering RNA (siRNA) pipeline products, one ...

The MarketWatch News Department was not involved in the creation of this content. NANJING, China, Feb. 24, 2026 /PRNewswire/ -- Frontier Biotechnologies Inc. (hereinafter referred to as "Frontier ...